These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy. Heredia D, Terés J, Orteu N, Rodés J. J Hepatol; 1988 Aug; 7(1):106-10. PubMed ID: 3053887 [Abstract] [Full Text] [Related]
4. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Riggio O, Balducci G, Ariosto F, Merli M, Pieche U, Pinto G, Tremiterra S, Ziparo V, Capocaccia L. Dig Dis Sci; 1989 Jun; 34(6):823-9. PubMed ID: 2656134 [Abstract] [Full Text] [Related]
5. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose. Riggio O, Balducci G, Ariosto F, Merli M, Tremiterra S, Ziparo V, Capocaccia L. Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931 [Abstract] [Full Text] [Related]
6. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. Morgan MY, Hawley KE, Stambuk D. J Hepatol; 1987 Apr; 4(2):236-44. PubMed ID: 3295020 [Abstract] [Full Text] [Related]
7. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Morgan MY, Hawley KE. Hepatology; 1987 Apr; 7(6):1278-84. PubMed ID: 3315932 [Abstract] [Full Text] [Related]
13. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Lanthier PL, Morgan MY. Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914 [Abstract] [Full Text] [Related]
14. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL, Vilstrup H, Morgan MY. Cochrane Database Syst Rev; 2016 Apr 18; 4():CD003044. PubMed ID: 27089005 [Abstract] [Full Text] [Related]
15. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S. Hepatology; 1997 Jun 18; 25(6):1351-60. PubMed ID: 9185752 [Abstract] [Full Text] [Related]
16. [1st use of lactitol in the treatment of porto-systemic encephalopathy]. Bircher J, Bührer M, Franz K, van Velthuijsen JA. Schweiz Med Wochenschr; 1982 Sep 18; 112(38):1306-7. PubMed ID: 7134954 [Abstract] [Full Text] [Related]
17. Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis. Cammà C, Fiorello F, Tinè F, Marchesini G, Fabbri A, Pagliaro L. Dig Dis Sci; 1993 May 18; 38(5):916-22. PubMed ID: 8482191 [Abstract] [Full Text] [Related]